As per Future Market Insights’ latest industry analysis, the valuation for the global antiepileptic drugs industry is estimated to be around US$ 17.3 Billion in 2022, and is projected to exhibit growth at a CAGR close to 4.3% over the forecast period, with an estimated valuation to be around US$ 26.2 Billion by 2032. Epilepsy …